Leman Biotech

Develope rof AI-based platform for cancer immunotherapy

placeShenzhen, Guangdong Province, China calendar_todayFounded 2021 language lemanbio.com

Social engagement

Social engagement: 2.8K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include FUHO Capital Management.

Investor typeCountShare
Venture capital444%
Other / undisclosed556%

Recent activity

8 Jun 2026
Event
EHA 2026 Congress
30 Apr 2026
Event
ASGCT Annual Meeting 2026
16 Mar 2026
Milestone
regulatory
Coming soon